SSH1 and hepatocellular carcinoma: Consistent with these reports, the present study demonstrated, for the first time to the best of our knowledge, that SSH1 is aberrantly expressed in HCC and that this overexpression of SSH1 is prognostic of poor clinical outcome in patients with HCC (Figures 1, 2).